Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
about
Revisiting AMPA receptors as an antiepileptic drug targetAdvances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum DisorderRegulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsyIon channels as drug targets in central nervous system disordersNew and emerging treatments for epilepsy: review of clinical studies of lacosamide, eslicarbazepine acetate, ezogabine, rufinamide, perampanel, and electrical stimulation therapy[Brivaracetam for add-on treatment in focal epilepsy].A swell in the armamentarium of antiepileptic drug targetsEfficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.Role of the Ion Channel Extracellular Collar in AMPA Receptor GatingNeurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy.Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.Synthetic neurosteroids on brain protectionCarisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasmsPotassium channel activator attenuates salicylate-induced cochlear hearing loss potentially ameliorating tinnitusThe AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damageConserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy.Neuroendocrine aspects of catamenial epilepsyNew drug classes for the treatment of partial onset epilepsy: focus on perampanel.Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.Treatment of infantile spasms: emerging insights from clinical and basic science perspectives.Novel medications for epilepsy.Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.Recent and future antiepileptic drugs and their impact on cognition: what can we expect?Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.Methodologies used to identify and characterize interactions among antiepileptic drugs.New AMPA antagonists in epilepsy.Why are antiepileptic drugs used for nonepileptic conditions?Emerging drugs for focal epilepsy.Investigating psychotropic properties of antiepileptic drugs.Brivaracetam for the treatment of epilepsy in adults.A randomized controlled trial of ganaxolone in posttraumatic stress disorder.The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.Current role of perampanel in pediatric epilepsy.Brivaracetam for the treatment of epilepsy.Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Carisbamate blockade of T-type voltage-gated calcium channels.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).
P2860
Q24611163-F1ED1DF1-71A1-4503-8624-29BF7F653F1CQ26781265-28892825-96DC-4489-9E26-BFB552FC92EFQ26859135-4DDE2266-4C35-4FC5-9207-CBB225279B1DQ27004533-FCBD4C08-21D5-4C26-AFFF-F50E15B83BF8Q27007942-24A4FFB4-D636-4835-A387-F3914680DCB1Q30390285-BC4B5468-F705-40BF-AD02-0205D42CE2F2Q30429603-8376500F-5359-4F93-9703-FBB87D39EEB1Q30560643-EADC19FA-1855-4569-BD9D-02DFE7BDA9D5Q30850624-66F2F348-56C6-4550-95E8-BC69CF328C2EQ34065134-4C6D2B5A-6889-4464-B9FA-3FD8760857D4Q34379505-DCA15648-1569-4733-A101-9EC67ADF3415Q35083179-F12027A1-CDD9-4F6C-9ADC-2D1402DBB21AQ35169910-94E921A1-5A55-46F2-992B-CA033B67C150Q35204540-E227E32A-141C-4BA6-BFFE-18F0BC92519FQ35296511-8353335E-A6D4-4A1C-BD20-40BDF593B00FQ35537344-7189791A-1DCF-4BDC-8794-486D5925A931Q35659046-E82F0365-0366-4773-8EBE-80BBF29B56F4Q35794579-1BE7DEB0-7BFE-4779-A281-B88E604758F8Q35971997-F755DF23-E902-494D-B065-E3D9EA30F4F3Q36173874-042CB547-CA2D-4877-B2C1-593C2411ACEAQ37014640-521F85F8-6D4B-4F05-91BB-E066A7B45092Q37131951-4AD3DB14-74D4-4EF1-ABAA-EF9EE2F466D9Q37896402-FDA1C119-C645-4D06-9738-2F53C38CA452Q37950518-BDC714A1-9479-487E-9F48-6710CE870944Q37992162-92ABEB31-280A-4368-8138-952EE1ED7576Q38014887-61B65DAB-56B4-420B-9DEB-53AC46132E00Q38014890-E36E7C5E-E26E-4010-9647-57B0134E00B2Q38018676-95530C35-4F8F-4D05-A34E-E475E0432375Q38025721-AB4CB342-28A1-47F4-8262-CBBE573DC176Q38059891-440431BC-7614-4302-86FC-6DAC252FF567Q38062011-206DAF3C-F990-4BD4-ADDD-313A563B3584Q38112212-6B499698-5693-4DBE-AE5C-EEBBEAEB459AQ38195636-12C8B39A-D331-43BE-B146-1AEFAFB3A928Q38374699-0F904B1C-2334-4041-A9AA-7BEF34BDB722Q38621010-E610E9EA-517A-4AEA-B8ED-58C88B834D0EQ38675314-5999BA2A-CA1E-4C45-A576-E515393B6FC6Q38694479-50710376-D014-4370-98C9-1FBAC38E00DCQ38739649-3A2DA921-3CF2-4117-AAE4-36C67B3B57E7Q38946598-07F0A235-7459-42F3-B370-23279A544707Q39006241-51CC714C-7984-493E-99C8-DE8501D94DAB
P2860
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@en
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference
@nl
type
label
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@en
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference
@nl
prefLabel
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@en
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference
@nl
P2093
P1433
P1476
Progress report on new antiepi ...... th Eilat Conference (EILAT X).
@en
P2093
H Steve White
Meir Bialer
René H Levy
Svein I Johannessen
P304
P356
10.1016/J.EPLEPSYRES.2010.09.001
P577
2010-12-01T00:00:00Z